Integrium, LLC Selects Phase Forward IRT for Enhanced Clinical Trial Supply Management

Published: Apr 06, 2010

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Integrium LLC, a contract research organization (CRO) specializing in dermatology, cardiovascular and metabolic disease clinical research, recently signed an agreement for the use of Phase Forwardâ„¢ IRT.

Back to news